We serve Chemical Name:2-Amino-4-(methylsulfonyl)phenol CAS:98-30-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-Amino-4-(methylsulfonyl)phenol
CAS.NO:98-30-6
Synonyms:2-amino-4-methylsulfonylphenol;2-Amino-4-(methylsulfonyl)phenol;Phenol, 2-amino-4-(methylsulfonyl)-;1103750;ZR BQ ESW1;EINECS 202-654-4
Molecular Formula:C7H9NO3S
Molecular Weight:187.216
HS Code:2922299090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:436.3±45.0 °C at 760 mmHg
Density:1.4±0.1 g/cm3
Index of Refraction:1.603
PSA:88.77000
Exact Mass:187.030319
LogP:-1.05
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 2-amino-4-methylsulfonylphenol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,EINECS 202-654-4 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Amino-4-(methylsulfonyl)phenol Use and application,1103750 technical grade,usp/ep/jp grade.
Related News: Beta Bionics, Inc. recently announced it has received Breakthrough Device designation from the US FDA for its investigational iLet Bionic Pancreas System. 2-Amino-4-(methylsulfonyl)phenol manufacturer The Darzalex-Rd regimen got its FDA go-ahead in transplant-ineligible patients in 2019 based on data from the same phase 3 MAIA trial showing it could pare down the risk of disease progression or death by 44% after a median follow-up of 28 months. Now, after 56.2 months of follow-up, over half of Darzalex patients were still alive without their disease worsening, a showing that’s again “unprecedented” for a front-line myeloma treatment, Tendler said. 2-Amino-4-(methylsulfonyl)phenol supplier This is particularly important in reducing overall disease burden. Moreover, this strategic decision will not only strengthen our diabetes portfolio but also help consolidate our position as the fastest-growing player in the anti-diabetes segment, Mankind Pharma Director of Marketing Sanjay Koul said in a statement. 2-Amino-4-(methylsulfonyl)phenol vendor This is particularly important in reducing overall disease burden. Moreover, this strategic decision will not only strengthen our diabetes portfolio but also help consolidate our position as the fastest-growing player in the anti-diabetes segment, Mankind Pharma Director of Marketing Sanjay Koul said in a statement. 2-Amino-4-(methylsulfonyl)phenol factory The Company��s immuno-oncology product candidates include natural killer (NK) cell and T-cell cancer immunotherapies, which are designed to synergize with well-established cancer therapies, including immune checkpoint inhibitors and monoclonal antibodies, and to target tumor-associated antigens with chimeric antigen receptors (CARs).
